We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
42 hedge funds and large institutions have $175M invested in Evelo Biosciences, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
11% more funds holding
Funds holding: 38 → 42 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
32% less capital invested
Capital invested by funds: $258M → $175M (-$82.3M)
Holders
42
Holders Change
+4
Holders Change %
+10.53%
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
5
Increased
15
Reduced
10
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$670K |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$434K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$419K |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$354K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$220K |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$2.42M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$397K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$53.8K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$51K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$17.2K |
